Meta Analysis of the Curative Effect of Reduced Glutathione in the Treatment of Liver Injury Caused by Anti-tuberculosis Drugs
Liu Yi,Gao Di,Liu Enyi,Huang Lin,Sun Hongmei,Zhao Libo,Feng Wanyu
DOI: https://doi.org/10.3969/j.issn.1672-5433.2013.01.003
2013-01-01
Abstract:Objective: To evaluate the efficacy and safety of reduced glutathione in the treatment of liver injury caused by anti-tuberculosis drugs. Methods: The literature analysis based on evidence-based medicine was performed. The clinical research data on the efficacy of reduced glutathione in the treatment of liver injury caused by anti-tuberculosis drugs were searched from CBM, CNKI, MEDLINE, EMbase and Cochrane central register of controlled trials (CENTRAL). The quality of included studies was evaluated and the effective data extracted. RevMan5.0 software was used for the data analysis. Results: The meta analysis of 13 randomized controlled trials showed that the total effective rate [RR = 1.36,95%CI(1.16,1.59),P = 0.000 2], ALT[MD = -34.55,95%CI(-39.17, -29.93),P < 0.000 01],AST[MD = -34.62, 95%CI(-40.71, -28.53),P < 0.000 01], TBiL[MD = -18.57,95%CI(-31.40, -5.75),P = 0.005] in treatment group was better than control group. Conclusion: The clinical curative effect of reduced glutathione was good for the treatment of liver injury induced by anti-tuberculosis drugs. But the less quantity of samples enrolled in the study may reduced the reliability of the results. More reasonable design, strict implementation, multi-center and large sample randomized double-blind controlled trials are needed to further confirm the study results.